PDCD1 and cancer: Academic hospitals have been recruiting patients in clinical trials to investigate autologous, PD-1 knocked out T cells for the treatment of multiple types of cancer, including solid tumors arising from the esophagus,61 lung,62 prostate,63 and Epstein-Barr-related neoplasms.64